Yeditepe Üniversitesi

Taha Bartu Hayal

Fikrettin Sahin

Pakize Neslihan Tasli

Oguz Kaan Kirbas

Batuhan Turhan Bozkurt

Berna Bulbul

Seda Beyaz

Use of nano-sized lead borate compounds for treatment purposes due to their selective anticancer activity on p53 mutant breast cancer cell line, T47D is disclosed. The method of synthesizing nano-sized lead borates of the present invention comprises the steps of preparing a borate buffer solution by sodium hydroxide and boric acid, dissolving lead nitrate (and preferably PEG) in distilled water by stirring, mixing the borate buffer solution with the lead nitrate (and preferably PEG) solution, washing the resulting solution with distilled water and drying to remove the impurities.

Use of mutant P53 gene targeted lead borate nanoparticles in cancer treatment and production method of these nanoparticles

Use of nano-sized lanthanide borate (erbium borate and dysprosium borate) compounds for wound treatment due to their significant level of wound healing effect on the cells is disclosed. In the scope of the invention, the synthesis of nanometer-sized erbium borate and dysprosium borate compound by buffered-precipitation method at room conditions and the use of these compounds in biological applications are discussed.

Use of nano-sized lanthanide borate (dysprosium borate and erbium borate) compounds for wound healing purposes and production method thereof

Growing community of inventors

Istanbul, Turkey

Taha Bartu Hayal